Niels Jacobsen, Chairman of the Board of Directors, born 1957, residing in Denmark. He became a Board Member in 2005 and has been the Chairman of the Board since 2006. Mr. Jacobsen is president and CEO of William Demant Holding A/S, a Danish industrial group in the hearing healthcare field. Previous positions include president of Orion A/S and vice president in corporate affairs for both Atlas Danmark A/S and Thrige-Titan A/S. Mr. Jacobsen is also a board member of a number of Danish companies and organizations, including LEGO A/S (chairman), KIRKBI A/S (vice chairman), A.P. Møller Mærsk A/S and he holds directorships in a number of wholly and partly owned companies in the William Demant Group, including Oticon A/S (chairman), William Demant Invest A/S (chairman), Sennheiser Communications A/S (chairman), HIMPP A/S (chairman), HIMSA A/S (chairman) and HIMSA II A/S. Furthermore, he holds a seat on the central board of the Confederation of Danish Industries.
Mr. Jacobsen has a MSc degree in Economics from the University of Aarhus in Denmark. He and his related parties hold 107,500 shares in the Company, but he holds no share options in the Company. Mr. Jacobsen is chairman of the board of William Dement Invest, the Company’s largest shareholder, which holds 168,694,203 shares in the Company. He has no interest links with the Company’s main clients or competitors.
Thordur Magnusson, Vice Chairman of the Board of Directors, born 1949, residing in Iceland. He became a Board Member in 2005 and has been the Vice Chairman of the Board since 2006. Mr. Magnússon is the chairman of the investment company Eyrir Invest. He is also a board member of numerous Icelandic companies, including the retail companies Byko, Kaupás and Norvik and is chairman of the board of Marorka, an energy-efficiency systems company, as well as Calidris and Handpoint. Mr. Magnússon is also a member of the board of the Iceland Chamber of Commerce and University of Reykjavík.
Mr. Magnússon was CFO at Eimskip for over 20 years. He has a Business degree from the University of Iceland and holds an MBA from the University of Minnesota in the United States. Mr. Magnússon and related parties hold 8,456 shares in the Company, but he holds no share options. Mr. Magnússon is chairman of the board and a major shareholder in Eyrir Invest, the Company’s second-largest shareholder, which holds 68,540,215 shares in the Company. He has no interest links with the Company’s main clients or competitors.
Arne Boye Nielsen,Member of the Board of Directors, born in 1968, residing in Denmark. He became a Board Member in 2009. Mr. Nielsen has spent his entire career with William Demant Holding A/S in various and expanding roles throughout the world. After working as a management assistant to Mr. Niels Jacobsen and as an interim general manager of Oticon Australia Pty Ltd., Mr. Nielsen assumed in 1996 his current position as President of Diagnostic Instruments which has operations worldwide. In 2003 he became a member of the management group in William Demant Holding A/S. Mr. Nielsen is a member of the board of Sennheiser Communications A/S and Phonic Ear A/S as well as president of Interacoustics A/S and director of Maico Diagnostic in Berlin, Germany.
Mr. Nielsen has a BSc degree and a MSc degree in Business Administration from the Copenhagen Business School in Denmark. He neither has shares nor share options in the Company. Mr. Nielsen was nominated to the Board by William Demant Invest, the Company’s largest shareholder. He has no interest links with the Company’s main clients or competitors.
Kristjan Tómas Ragnarsson,Member of the Board of Directors, born in 1943, residing in the United States. He became a Board Member in 1999. Mr. Ragnarsson is chairman and Lucy G. Moses professor at department of rehabilitation medicine at Mount Sinai School of Medicine, New York, United States. He is a specialist in physical medicine and rehabilitation, certified by the American Board of Physical Medicine and Rehabilitation and has been practicing physician and academician for more than 40 years. Mr. Ragnarsson is currently an executive trustee of the American Scandinavian Foundation, president of the Association of Academic Physiatrists and vice president of the Foundation for Physical Medicine and Rehabilitation. Previous positions include president of American Spinal Injury Association, chairman of the board of governors Mount Sinai Faculty Practice Associates and trustee at the Mount Sinai Hospital.
Mr. Ragnarsson graduated as a medical doctor from the School of Medicine of the University of Iceland. Mr. Ragnarsson and related parties hold 623,789 shares in the Company, but he holds no share options. Mr. Ragnarsson has no interest links with the Company’s main clients, competitors or major shareholders.
Svafa Gronfeldt,
Member of the Board of Directors, born in 1965, currently residing in the United States. She became a Board Member in 2008. Ms. Grönfeldt is the Chief Organizational Development Officer of Alvogen, an American generic pharmaceutical company. Previous positions include president of Reykjavík University, deputy to the CEO of Actavis Group hf., assistant professor in the Faculty of Economics and Business Administration at the University of Iceland and managing director and managing partner of IMG Gallup/Deloitte.
Ms. Grönfeldt holds a doctorate in industrial relations from the London School of Economics. She neither holds shares nor share options in the Company. Ms. Grönfeldt has no interest links with the Company’s main clients, competitors or major shareholders.